

Author: D'Oca Gino Sklan Alexandra Komatani Takeshi S
Publisher: Future Science
ISSN: 2046-8954
Source: Pharmaceutical Patent Analyst, Vol.2, Iss.3, 2013-05, pp. : 303-308
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Sklan Alexandra Komatani Takeshi S
Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. :


By Sklan Alexandra Komatani Takeshi S
Pharmaceutical Patent Analyst, Vol. 2, Iss. 4, 2013-07 ,pp. :






Pharmaceutical Research, Vol. 20, Iss. 10, 2003-10 ,pp. :